Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks.

EB, Schron; DV, Exner; Q, Yao; LS, Jenkins; JS, Steinberg; JR, Cook; SP, Kutalek; PL, Friedman; RS, Bubien; RL, Page; J, Powell

doi:10.1161/hc0502.103330

Public

Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks.

Shared by NobleBlocks on Feb 1, 2002 • 12:00 AM UTC

Authors:

Schron EB

Exner DV

Yao Q

Abstract

Background Implantable cardioverter defibrillator (ICD) use reduces mortality in patients with serious ventricular arrhythmias compared with antiarrhythmic drug (AAD) use. However, the relative impact of these therapies on self-perceived quality of life (QoL) is unknown.Methods and results Three sel...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!